Featured Research
Latest Research View All
News
Pharmacies Excluded from Preferred Networks Face Much Higher Risk of Closure
Featured Experts: Dima M. Qato
In The News View All
POLITICO
“Most Favored Nation” could incentivize drugmakers to pull products overseas, hurting patients worldwide, Lakdawalla warns
ABC7
Pharmaceutical tariffs may raise prices and reduce innovation, explains Padula
Featured Experts: William Padula
Modern Healthcare
States are likely to pursue PBM legislation in the absence of federal action, Joyce says
Featured Experts: Geoffrey Joyce
ABC News
Padula says pharmaceutical tariffs could hit R&D budgets
Featured Experts: William Padula
CNBC
HHS staffing cuts and reorganization are unlikely to boost department efficiency, Kanter says
Featured Experts: Genevieve P. Kanter
Featured White Paper
Fixing Medicare Advantage With Competitive Bidding
Schaeffer experts recommend using competitive bidding for standardized benefits to set plan payments and enhance beneficiary choice in Medicare Advantage.
Experts: Paul Ginsburg, Steve M. Lieberman
Medicare Advantage View All
Perspective
Medicare Advantage is Covering More and More Americans—Some Because They Don’t Get to Choose
Featured Experts: Grace McCormack, Victoria Shier
In The News View All
Commonwealth Fund
Do Medicare Advantage Provider Networks Change the Way Beneficiaries Use Health Care?
Featured Experts: Grace McCormack, Erin Trish
Modern Healthcare
Trish explains why some insurers are prioritizing MA over Part D
Featured Experts: Erin Trish
STAT
Ginsburg interviewed about his Medicare reform proposals
Featured Experts: Paul Ginsburg
Fortune
Some beneficiaries may find it hard to get an affordable Medigap plan, Ginsburg explains
Featured Experts: Paul Ginsburg
Axios
Medicare Advantage overpayments higher than estimated, Schaeffer study finds
Featured Experts: Paul Ginsburg, Steve M. Lieberman